AZITHROMYCIN TABLETS

Contract SPE2D2-22-D-0143 is a national award issued by the Defense Logistics Agency DLA Troop Support to Avkare, LLC for the procurement of Azithromycin tablets in various dosages and counts. The contract is valued at an estimated 4,256,797.10 dollars over a five year period, consisting of a base year and four option years, with an annual projected demand of 851,359.42 dollars. The supplies include 250 MG, 500 MG, and 600 MG tablets in multiple bottle counts, with fixed unit pricing across all option years. Performance is governed by FOB Destination terms, and the contract includes a HUBZone small business set-aside. Administrative updates to the contract include modification P00005, which updated the National Drug Code for the 600 MG tablets and changed the manufacturing facility to Pliva Hrvatska d.o.o. in Croatia. Additionally, modification P00008 exercised Option 4 for the period of March 24, 2026, through March 23, 2027. The contractor is required to comply with various federal regulations, including DFARS cybersecurity standards for safeguarding covered defense information and reporting requirements for executive compensation and greenhouse gas emissions. Inspection and acceptance are conducted by the government at the destination.